Admelog and Tofacitinib Extended-Release Tablets
Determining the interaction of Admelog and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: n.a.
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Admelog-Tofacitinib Tablets
- Admelog-Tofranil
- Admelog-Tofranil injection
- Admelog-Tofranil-PM
- Admelog-Tol-Tab
- Admelog-Tolazamide
- Tofacitinib Extended-Release Tablets-Admelog (Insulin Lispro (U-100) Cartridges and Pens)
- Tofacitinib Extended-Release Tablets-Admelog (Insulin Lispro (U-100) Vials)
- Tofacitinib Extended-Release Tablets-Ado-trastuzumab emtansine
- Tofacitinib Extended-Release Tablets-Ado-trastuzumab emtansine Intravenous
- Tofacitinib Extended-Release Tablets-Adox Pak 2/100
- Tofacitinib Extended-Release Tablets-Adoxa